Moleculary targeted auger electron radiation therapy for breast cancer: A clinical trial.

Moleculary targeted auger electron radiation therapy for breast cancer: A clinical trial.

Bibliographic Details
Main Authors:	Vallis, K, Reilly, R, Scollard, D, Chen, P, Wang, J, Petronis, J
Format:	Conference item
Published:	2004

Similar Items

Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy
by: Terry, S, et al.
Published: (2012)

Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
by: Terry, S, et al.
Published: (2012)

Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
by: Cornelissen, B, et al.
Published: (2010)

Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
by: Reilly, R, et al.
Published: (2006)

Auger electrons for cancer therapy – a review
by: Anthony Ku, et al.
Published: (2019-10-01)

Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
by: Bailey, K, et al.
Published: (2007)

A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer
by: Vallis, K, et al.
Published: (2005)

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
by: Costantini, D, et al.
Published: (2010)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
by: Costantini, D, et al.
Published: (2008)

Auger electron therapy using In-111-labelled F3 peptide
by: Cornelissen, B, et al.
Published: (2011)

Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
by: Vallis, K, et al.
Published: (2014)

(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
by: Costantini, D, et al.
Published: (2007)

Utilizarea biomarkerior moleculari și celulari în epilepsie (reviul literaturii).
by: Cornelia Călcîi, et al.
Published: (2020-10-01)

The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
by: Chen, P, et al.
Published: (2001)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
by: Cornelissen, B, et al.
Published: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
by: Cornelissen, B, et al.
Published: (2012)

111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
by: Cornelissen, B, et al.
Published: (2012)

Synthesis of Moleculary Imprinted Polymer Originated from TFMAA and TRIM for Sterol Separation
by: Chinakrit Ladadok, et al.
Published: (2018-08-01)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
by: Jackson, M
Published: (2013)

MAGNEŢI MOLECULARI – TRECEREA DE LA LIGANZI DE TIP SALEN SPRE TIOSEMICARBAZONE
by: USM ADMIN
Published: (2015-12-01)

MAGNEŢI MOLECULARI – TRECEREA DE LA LIGANZI DE TIP SALEN SPRE TIOSEMICARBAZONE
by: Mihail SECU
Published: (2016-02-01)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
by: Cornelissen, B, et al.
Published: (2011)

Nanostructures as Radionuclide Carriers in Auger Electron Therapy
by: Nasrin Abbasi Gharibkandi, et al.
Published: (2022-02-01)

Auger electron radionuclide therapy utilising F3 peptide to target the nucleolus
by: Hillyar, C
Published: (2015)

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
by: Ramya Ambur Sankaranarayana, et al.
Published: (2022-09-01)

Optically driving the radiative Auger transition
by: Clemens Spinnler, et al.
Published: (2021-11-01)

La-135 as an Auger-electron emitter for targeted internal radiotherapy
by: Fonslet, J, et al.
Published: (2017)

A phase I trial of In-111-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer
by: Vallis, K, et al.
Published: (2008)

Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
by: Ramya Ambur Sankaranarayanan, et al.
Published: (2023-02-01)

Single cell S-value calculations of a stochastic cascade model for Auger-electron emitting radionuclides
by: Vallis, K, et al.
Published: (2016)

Augers and auger bits
by: 8096 British Standards Institution

Internalization of Auger electron-emitting isotopes into cancer cells: A method for spatial distribution determination of equivalent source terms
by: Vallis, K, et al.
Published: (2016)

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
by: Malick Bio Idrissou, et al.
Published: (2021-06-01)

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
by: Cai, Z, et al.
Published: (2008)

Scanning auger electron microscopy /
by: Prutton, M, et al.
Published: (2006)

123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).
by: Hu, M, et al.
Published: (2007)

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
by: Hu, M, et al.
Published: (2007)

Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus
by: Célia Fernandes, et al.
Published: (2022-06-01)

Angle resolved auger electron spectroscopy
by: Carr, P
Published: (1979)

CA selects : electron & auger spectroscopy
by: American Chemical Society
Published: (1979)